BenevolentBio is the drug discovery arm of BenevolentAI, a London based company focused on the application of AI to challenge the current process of drug development. The Company is backed by a strong institutional and corporate shareholder base. As an exploratory Research Scientist within BenevolentBio, you will help to build an exciting portfolio of novel pre-clinical drug discovery programs, across a range of therapeutic areas.
We have a number of openings for scientists to explore and develop new programs of research for BenevolentBio. Creative individuals with a range of experience are required to join our team of bioscientists in the identification and characterisation of new high quality targets for therapeutic intervention, across a range of human disease areas. Experience in establishing target rationale based on strong biological background, especially as applied to drug discovery and development is desirable, although applicants who have recently completed doctoral or post-doctoral studies will also be considered. The role will apply the Company’s proprietary technology platform that applies state-of-the-art artificial intelligence algorithms to carefully structured ‘big data’ sources, enabling target and pathway validation to tackle serious diseases with high unmet medical need.
Competitive salary, depending on experience, annual bonus, share options and comprehensive benefits.
If this challenge and opportunity excites you, please email your CV and a covering letter to email@example.com